Sun, Jul 13, 2014, 3:39 AM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Titan Pharmaceuticals Inc. Message Board

  • pharmas_123 pharmas_123 Nov 9, 2012 9:44 PM Flag

    Key Point

    The outpatient treatment of opioid addiction with daily dosed sublingual buprenorphine formulations represented a $1.3 billion market in the U.S. in 2011, and a seven day transdermal patch formulation of buprenorphine for the treatment of chronic pain was launched in the U.S. in 2011.


    TTNP had successful Phase III results and NDA submitted and asked priority review... and Partnership is behind the scene now.


Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.